Catalyst Pharmaceuticals (CPRX) Change in Acquisitions & Divestments (2013 - 2022)

Catalyst Pharmaceuticals' Change in Acquisitions & Divestments history runs 8 years deep, the most recent figure standing at $9.9 million for Q3 2022.

• Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $9.9 million in Q3 2022, while the trailing twelve-month figure through Dec 2022 was $9.9 million (changed N/A YoY) and the FY2022 annual result came in at $19.2 million, changed N/A from the prior year.
• Change in Acquisitions & Divestments was $9.9 million for Q3 2022 at Catalyst Pharmaceuticals, up from $5.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $31.7 million in Q4 2019 and bottomed at $5.0 million in Q1 2020.
• A 4-year average of $14.4 million and a median of $10.0 million in 2019 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2019 — Change in Acquisitions & Divestments jumped 122.95% — and 2020, when it tumbled 75.49%.
• Catalyst Pharmaceuticals' Change in Acquisitions & Divestments stood at $14.2 million in 2018, then soared by 122.95% to $31.7 million in 2019, then tumbled by 84.21% to $5.0 million in 2020, then jumped by 97.36% to $9.9 million in 2022.
• Business Quant data shows CPRX's Change in Acquisitions & Divestments at $9.9 million in Q3 2022, $5.0 million in Q1 2020, and $31.7 million in Q4 2019.